Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonaventure

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 10, 2020
Discovery and SAR studies of 2-alkyl-3-phenyl-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepines as 5-HT<sub>7/2</sub> inhibitors leading to the identification of a clinical candidateCurt A Dvorak, Dale A Rudolph, Diane Nepomuceno, et al.
The Journal of Comparative Neurology|August 26, 2010
Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brainCraig M Smith, Pei-Juan Shen, Avantika Banerjee, et al.
Annals of the New York Academy of Sciences|May 7, 2009
Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous systemSteven W Sutton, Jonathan Shelton, Craig Smith, et al.
Pharmacology Research & Perspectives|February 19, 2019
Mutagenesis of GPR139 reveals ways to create gain or loss of function receptorsLien Wang, Grace Lee, Amy Shih, et al.
Plos One|October 22, 2020
Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroidsGrace Woodruff, Naomi Phillips, Cassiano Carromeu, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 ReceptorCurt A Dvorak, Heather Coate, Diane Nepomuceno, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonistsBrock T Shireman, Curt A Dvorak, Dale A Rudolph, et al.
Cellular and Molecular Life Sciences : CMLS|July 6, 2024
In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-BDavia Prischich, Rosalba Sortino, Alexandre Gomila-Juaneda, et al.
Alcohol (Fayetteville, N.Y.)|December 15, 2010
The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxietyAndrea Cippitelli, Amir H Rezvani, J Elliott Robinson, et al.
Psychoneuroendocrinology|January 15, 2016
Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause modelLauren M Federici, Izabela Facco Caliman, Andrei I Molosh, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|November 10, 2020
Discovery and SAR studies of 2-alkyl-3-phenyl-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepines as 5-HT<sub>7/2</sub> inhibitors leading to the identification of a clinical candidateCurt A Dvorak, Dale A Rudolph, Diane Nepomuceno, et al.
The Journal of Comparative Neurology|August 26, 2010
Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brainCraig M Smith, Pei-Juan Shen, Avantika Banerjee, et al.
Annals of the New York Academy of Sciences|May 7, 2009
Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous systemSteven W Sutton, Jonathan Shelton, Craig Smith, et al.
Pharmacology Research & Perspectives|February 19, 2019
Mutagenesis of GPR139 reveals ways to create gain or loss of function receptorsLien Wang, Grace Lee, Amy Shih, et al.
Plos One|October 22, 2020
Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroidsGrace Woodruff, Naomi Phillips, Cassiano Carromeu, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 ReceptorCurt A Dvorak, Heather Coate, Diane Nepomuceno, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonistsBrock T Shireman, Curt A Dvorak, Dale A Rudolph, et al.
Cellular and Molecular Life Sciences : CMLS|July 6, 2024
In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-BDavia Prischich, Rosalba Sortino, Alexandre Gomila-Juaneda, et al.
Alcohol (Fayetteville, N.Y.)|December 15, 2010
The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxietyAndrea Cippitelli, Amir H Rezvani, J Elliott Robinson, et al.
Psychoneuroendocrinology|January 15, 2016
Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause modelLauren M Federici, Izabela Facco Caliman, Andrei I Molosh, et al.
Pageof 10